Burnham & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.99M Sell
7,773
-344
-4% -$406K 7.1% 1
2026
Q2
$9.7M Sell
8,117
-191
-2% -$195K 7.85% 1
2026
Q1
$7.64M Buy
+8,308
New +$8.42M 7.23% 1

Other funds holding LLY

Burnham & Co's LLY Position: Q3 2026 in Review

Burnham & Co reduced its Eli Lilly (LLY) stake by 4.2% in Q3 2026, selling an estimated $406K and leaving 7,773 shares worth $8.99M. The position accounts for 7.1% of the portfolio, ranked #1.

Burnham & Co first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. The position peaked at $9.7M in Q2 2026. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Burnham & Co held 7,773 shares of Eli Lilly worth $8.99M as of Q3 2026.
  • Burnham & Co sold 344 Eli Lilly shares in Q3 2026, an estimated $406K.
  • Eli Lilly made up 7.1% of Burnham & Co's portfolio in Q3 2026, its #1 holding.
  • Burnham & Co first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
  • Burnham & Co's Eli Lilly position peaked at $9.7M in Q2 2026.
  • 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Burnham & Co's 13F filing for Q3 2026, filed 12 Nov 2026.